Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Grifols SA (NASDAQ:GRFS)

21.71
Delayed Data
As of Apr 28
 +0.54 / +2.55%
Today’s Change
14.27
Today|||52-Week Range
21.77
+35.10%
Year-to-Date
Akebia Therapeutics (AKBA) Shows Strength: Stock Up 5.8%
Apr 28 / Zacks.com - Paid Partner Content
Zacks.com featured highlights: Arbor Realty, Commercial Vehicle Group, Grifols, S.A.,...
Apr 20 / Zacks.com - Paid Partner Content
Glaxo (GSK) Reports In-Line Q1 Earnings, Reiterates View
Apr 27 / Zacks.com - Paid Partner Content
GENOCEA BIOSCIENCES (GNCA) Catches Eye: Stock Gains 7.1%
Apr 20 / Zacks.com - Paid Partner Content
Celgene (CELG) Tops on Q1 Earnings, Sales Miss, Raises View
Apr 27 / Zacks.com - Paid Partner Content
How to Uncover Institutional Buying
Apr 19 / Zacks.com - Paid Partner Content
AbbVie (ABBV) Presents Positive Data on HCV Combination Drug
Apr 21 / Zacks.com - Paid Partner Content
AMAG Files for FDA Approval of Subcutaneous Form of Makena
Apr 18 / Zacks.com - Paid Partner Content
Nivalis' (NVLS) Shares Down After Merger Deal with Alpine
Apr 20 / Zacks.com - Paid Partner Content
Ohr Pharmaceutical (OHRP) Jumps: Stock Adds 15% in Session
Apr 18 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close21.17
Today’s open21.16
Day’s range21.13 - 21.77
Volume1,283,870
Average volume (3 months)659,205
Market cap$5.7B
Dividend yield2.52%
Data as of 4:00pm ET, 04/28/2017

Growth & Valuation

Earnings growth (last year)+3.24%
Earnings growth (this year)--
Earnings growth (next 5 years)+12.16%
Revenue growth (last year)+2.94%
P/E ratio--
Price/Sales2.46
Price/Book3.78

Competitors

 Today’s
change
Today’s
% change
UTHRUnited Therapeutics ...+5.20+4.32%
IONSIonis Pharmaceutical...+0.63+1.32%
MNKMallinckrodt Plc+0.54+1.16%
TAROTaro Pharmaceutical ...+0.35+0.30%
Data as of 4:02pm ET, 04/28/2017

Financials

Next reporting dateMay 3, 2017
EPS forecast (this quarter)$0.24
Annual revenue (last year)$4.5B
Annual profit (last year)$602.1M
Net profit margin13.47%

Profile

Sector
Health Technology
Industry
Biotechnology
Joint Chief Executive Officer &
Director
Raimon Grifols Roura
Joint Chief Executive Officer &
Director
Victor Grifols Deu
Corporate headquarters
Barcelona, Catalonia

Forecasts